Chemoprevention for neurofibromatosis 2: just over the horizon?

Autor Plotkin, Scott R.
Vydáno 2014

Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis

Autor Blakeley, Jaishri O., Plotkin, Scott R.
Vydáno v Neuro Oncol (2016)

INNV-20. UTILITY OF TELEHEALTH FOR SPECIALTY NEUROFIBROMATOSIS (NF) CARE

Autor Jordan, Justin, Seijo, Marlon, Merker, Vanessa, Bhadola, Shivkumar, Thalheimer, Raquel, Plotkin, Scott R
Vydáno v Neuro Oncol (2018)

Clinical Features of Schwannomatosis: A Retrospective Analysis of 87 Patients

Autor Merker, Vanessa L., Esparza, Sonia, Smith, Miriam J., Stemmer-Rachamimov, Anat, Plotkin, Scott R.
Vydáno 2012

Outcomes of hospitalization in pregnant women with CNS neoplasms: a population-based study

Autor Terry, Anna R., Barker, Fred G., Leffert, Lisa, Bateman, Brian T., Souter, Irene, Plotkin, Scott R.
Vydáno 2012

Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schw...

Autor Merker, Vanessa L., Dai, Annie, Radtke, Heather B., Knight, Pamela, Jordan, Justin T., Plotkin, Scott R.
Vydáno v BMC Health Serv Res (2018)

Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients

Autor Plotkin, Scott R., Halpin, Chris, McKenna, Michael J., Loeffler, Jay S., Batchelor, Tracy T., Barker, Fred G.
Vydáno 2010

Effective Provider-Patient Communication of a Rare Disease Diagnosis: A Qualitative Study of People Diagnosed with Schwannomatosis

Autor Merker, Vanessa L., Plotkin, Scott R., Charns, Martin P., Meterko, Mark, Jordan, Justin T., Elwy, A. Rani
Vydáno v Patient Educ Couns (2020)

Expression of SMARCB1 (INI1) mutations in familial schwannomatosis

Autor Smith, Miriam J., Walker, James A., Shen, Yiping, Stemmer-Rachamimov, Anat, Gusella, James F., Plotkin, Scott R.
Vydáno 2012

mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition

Autor Beauchamp, Roberta L., Erdin, Serkan, Witt, Luke, Jordan, Justin T., Plotkin, Scott R., Gusella, James F., Ramesh, Vijaya
Vydáno v J Biol Chem (2020)

Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome

Autor Wang, Daphne L., Smith, Kelly B., Esparza, Sonia, Leigh, Fawn A., Muzikansky, Alona, Park, Elyse R., Plotkin, Scott R.
Vydáno 2012

Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth

Autor James, Marianne F., Lelke, Johanna M., MacCollin, Mia, Plotkin, Scott R., Stemmer-Rachamimov, Anat O., Ramesh, Vijaya, Gusella, James F.
Vydáno 2007

Improvement in patient-reported hearing after treatment with bevacizumab in people with Neurofibromatosis Type 2

Autor Huang, Victoria, Bergner, Amanda L., Halpin, Chris, Merker, Vanessa L., Sheridan, Monica R., Widemann, Brigitte, Blakeley, Jaishri O., Plotkin, Scott R.
Vydáno v Otol Neurotol (2018)

NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth

Autor James, Marianne F., Han, Sangyeul, Polizzano, Carolyn, Plotkin, Scott R., Manning, Brendan D., Stemmer-Rachamimov, Anat O., Gusella, James F., Ramesh, Vijaya
Vydáno 2009

Achieving consensus for clinical trials: The REiNS International Collaboration

Autor Plotkin, Scott R., Blakeley, Jaishri O., Dombi, Eva, Fisher, Michael J., Hanemann, C. Oliver, Walsh, Karin S., Wolters, Pamela L., Widemann, Brigitte C.
Vydáno 2013

Conclusions and future directions for the REiNS International Collaboration

Autor Widemann, Brigitte C., Blakeley, Jaishri O., Dombi, Eva, Fisher, Michael J., Hanemann, Clemens O., Walsh, Karin S., Wolters, Pamela L., Plotkin, Scott R.
Vydáno 2013

Correlation between NF1 genotype and imaging phenotype on whole-body MRI: NF1 radiogenomics

Autor Liu, Yunpeng, Jordan, Justin T., Bredella, Miriam A., Erdin, Serkan, Walker, James A., Vangel, Mark, Harris, Gordon J., Plotkin, Scott R., Cai, Wenli
Vydáno v Neurology (2020)

The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research

Autor Radtke, Heather B., Klein-Tasman, Bonita P., Merker, Vanessa L., Knight, Pamela, Ullrich, Nicole J., Jordan, Justin T., Korf, Bruce, Plotkin, Scott R.
Vydáno v Orphanet J Rare Dis (2021)

Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors

Autor Wong, Hon Kit, Lahdenranta, Johanna, Kamoun, Walid S., Chan, Annie W., McClatchey, Andrea I., Plotkin, Scott R., Jain, Rakesh K., di Tomaso, Emmanuelle
Vydáno v Cancer Res (2010)

The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities

Autor Klesse, Laura J., Jordan, Justin T., Radtke, Heather B., Rosser, Tena, Schorry, Elizabeth, Ullrich, Nicole, Viskochil, David, Knight, Pamela, Plotkin, Scott R., Yohay, Kaleb
Vydáno v Oncologist (2020)